Identification of Novel Markers of Human Lung Disease

Recruiting

• Conditions: Lung Diseases, Interstitial

• Registration Number: NCT02369575
• Lead Sponsor: Ohio State University

Brief Summary

The purpose of this study is to investigate new therapies for advanced lung disease.

Detailed Description

This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.

Study Timeline

• Study Start: 2015-02
• Study First Submitted: 2015-02-17
• Study First Submitted QC: 2015-02-23
• Study First Posted: 2015-02-24
• Status Verified: 2023-10
• Last Update Submitted: 2023-10-11
• Last Update Posted: 2023-10-12
• Primary Completion: 2030-02
• Study Completion: 2030-02

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• any one on lung transplant list

Exclusion Criteria

• HIV positive

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The development of novel therapeutics for interstial lung disease	10 years	Our research on these human lung cells will provide critical data which will aid in the diagnosis and treatment of a variety of different lung diseases, which have no cure.

Trial Locations

Locations (1)

Davis Heart and Lung Research Institute; 🇺🇸 Columbus, Ohio, United States